Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 175 participants.
Also called NCT05070494
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 175 participants
- Sponsor
- Registry
-
NCT05070494
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Thailand
- Registry status
- Unknown status
Technical summary
Registry record NCT05070494. Randomized; double masking; primary purpose treatment. Start 2021-03-01 (actual); primary completion 2022-04-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients
- Acronym
- Enhance
- Condition
- ESRD
- Condition
- Influenza Vaccine
- Condition
- Seroprotection
- Intervention (Biological)
- Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)
- Lead sponsor
- Mahidol University
- Collaborator
- Bhumirajanagarindra Kidney Institute, Thailand
- Collaborator
- Ministry of Health, Thailand
Record details
- Record id
cardio:ct-nct05070494- Content hash
9697065096fc469ca5fb9a2a93becde31daa1cd4cbab1332f30b8f9b90854151